GADSDEN REPORT
Don't Tread On The Truth
Economy & Markets

Novo Nordisk sued over weight-loss drug spin. Now it’s doing the exact same thing

Source: EXAMINER 4 views 0 comments
Novo Nordisk's CagriSema superiority claim over tirzepatide ignores dose context, repeating the PR spin it sued Eli Lilly over. Read more at EXAMINER ›
Read the full story at
EXAMINER
Open the original

The Gadsden Report aggregates and summarises headlines. The reporting above belongs to EXAMINER, and the link opens their page. This page exists so readers can find, share, and discuss the story here.

Inherit a million? You can invest. Have an economics doctorate? The SEC says you’re too dumb [EXAMINER]
DoorDash customer picks up order from driver at crash scene: 'I think that's my food right there' [FOX BIZ]
No, Israel isn’t ‘stolen land’ — it was purchased at astronomical premiums [EXAMINER]
The winner of the US-China rivalry won’t be the strongest. It will be the least broken [EXAMINER]
Florida Chamber gives JB Pritzker 'runner-up' for 'Economic Developer of the Year' award on Chicago billboards [FOX BIZ]
Capitalism, or why American oil production is surging [EXAMINER]

Discussion — 0 comments

No comments yet. Be the first.